Trump Executive Order Directs Cannabis Rescheduling
January 19, 2026
A New Orleans CPE getaway with Western CPE combines focused morning classes with open afternoons,
3 min read
Tax Byte
The DEA has begun the process to reclassify marijuana from a Schedule I drug (like heroin and LSD) to a Schedule III drug (like ketamine and anabolic steroids.) The proposal does not legalize recreational marijuana use, but it recognizes cannabis as a less dangerous drug and acknowledges its medical uses.
The move represents the DEA’s biggest policy shift in decades, and it’s likely to have far-reaching business and tax implications.
What are the tax and accounting implications of marijuana rescheduling?
Under Section 280E of the Internal Revenue Code, businesses involved in “trafficking” Schedule I and II substances may not claim deductions for what would otherwise be ordinary business expenses, such as payroll, marketing costs, and rent. As such, reclassifying marijuana as a Schedule III drug will drastically lower the tax obligations of cannabis businesses. It will also help cannabis businesses that are legal at the state level better compete with competitors who operate illegally.
Recent Stories
Trump Accounts and New Form 4547
January 12, 2026
The ACA Enhanced Subsidy Expires
January 2, 2026
IRS Premium Tax Credit FAQ Update: What to Know for 2026
December 30, 2025
Next Up...
Choosing the right hotel can shape your entire New Orleans CPE conference experience. Discover why
4 min read
A New Orleans CPE conference offers more than continuing education. With Western CPE, you enjoy
4 min read